Clinical Utility of Pre-Therapeutic [18F]FDG PET/CT Imaging for Predicting Outcomes in Breast Cancer
CONCLUSION: High TMTV in pre-therapeutic imaging is associated with no-pCR and recurrence. It can help in identifying high-risk patients and be considered as an intensified or alternative adjuvant therapy for closely monitoring patients.PMID:37685551 | DOI:10.3390/jcm12175487
Source: Clinical Genitourinary Cancer - Category: Cancer & Oncology Authors: Sophia Najid Romain-David Seban Laurence Champion Alexandre De Moura Clara Sebbag H élène Salaün Luc Cabel Claire Bonneau Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | HER2 | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Study